NEW YORK, March 14, 2011 /PRNewswire/ — Reportlinker.com
announces that a new market research report is available in its
Eliminate unnecessary risk with the industry benchmark in
comprehensive patent information.
Pipeline Developer is a regularly updated, professional patent
search performed by our expert team, which not only identifies
relevant patents, but delivers categorisation and interpretation,
all delivered by a convenient online interface.
The Pipeline Developer report covers Insulin Lispro
Insulin Lispro indications: Treatment of diabetes mellitus,
optionally in combination with a longer-acting insulin for type 1
diabetes or in a combination therapy with a sulfonylurea agent for
type 2 diabetes
Insulin Lispro innovator: Eli Lilly (Humalog, Humalog Kwikpen,
Humalog Mix 25, Humalog Mix25 Pen, Humalog Mix 50, Humalog Pen)
Imagine having your own team of pharmaceutical patent experts,
at a fraction of the cost and without the wait.
Used by the worlds leading generic pharmaceutical companies and
legal teams, Pipeline Developer minimises the risk of wasted
developments or legal action, by providing you with nothing less
than the very best in comprehensive patent information. Searched
and analysed by highly trained, dedicated staff using sophisticated
searching techniques, Pipeline Developer delivers results you can
rely on. And that means your staff can concentrate on how the
patent landscape affects your business, rather than trying to
source reliable patent information.